Atlas Trials

A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin

Clinical trial NCT07235189 · COMPLETED

Trial details

NCT number
NCT07235189
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2025-10-28
Primary completion
2026-01-28
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.